Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Pogarell

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Pharmacopsychiatry|December 13, 2005
Prolonged confusional state following electroconvulsive therapy--diagnostic clues from serial electroencephalographyO Pogarell, S Ehrentraut, T Rüther, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonismJ Schwarz, K Tatsch, T Gasser, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 1998
Parkinson's disease and tumour in the supplementary motor area: a re-evaluationA Kupsch, O Pogarell, J Schwarz, et al.
Advances in Gerontology = Uspekhi Gerontologii|June 3, 2017
EEG-neurofeedback training and quality of life of institutionalized elderly women (a pilot study)L Van Eijk, S A Zwijsen, D Keeser, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2002
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PETH Hampel, S J Teipel, G E Alexander, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
Costs of drug treatment in Parkinson's diseaseR C Dodel, K M Eggert, M S Singer, et al.
Pharmacopsychiatry|May 9, 2012
Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptomsO Pogarell, W Koch, S Karch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2002
Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre studyO Pogarell, T Gasser, J J van Hilten, et al.
Psychiatry Research. Neuroimaging|January 28, 2024
Neurofeedback for alcohol addiction: Changes in resting state network activity<sup>✰</sup>B Sanader Vukadinovic, S Karch, M Paolini, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 15, 2016
Short and long-term effects of sham-controlled prefrontal EEG-neurofeedback training in healthy subjectsH J Engelbregt, D Keeser, L van Eijk, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Pharmacopsychiatry|December 13, 2005
Prolonged confusional state following electroconvulsive therapy--diagnostic clues from serial electroencephalographyO Pogarell, S Ehrentraut, T Rüther, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonismJ Schwarz, K Tatsch, T Gasser, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 1998
Parkinson's disease and tumour in the supplementary motor area: a re-evaluationA Kupsch, O Pogarell, J Schwarz, et al.
Advances in Gerontology = Uspekhi Gerontologii|June 3, 2017
EEG-neurofeedback training and quality of life of institutionalized elderly women (a pilot study)L Van Eijk, S A Zwijsen, D Keeser, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2002
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PETH Hampel, S J Teipel, G E Alexander, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
Costs of drug treatment in Parkinson's diseaseR C Dodel, K M Eggert, M S Singer, et al.
Pharmacopsychiatry|May 9, 2012
Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptomsO Pogarell, W Koch, S Karch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2002
Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre studyO Pogarell, T Gasser, J J van Hilten, et al.
Psychiatry Research. Neuroimaging|January 28, 2024
Neurofeedback for alcohol addiction: Changes in resting state network activity<sup>✰</sup>B Sanader Vukadinovic, S Karch, M Paolini, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 15, 2016
Short and long-term effects of sham-controlled prefrontal EEG-neurofeedback training in healthy subjectsH J Engelbregt, D Keeser, L van Eijk, et al.
Pageof 6